[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 536
Citations 0
Lab Reports
June 2, 2015

Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis

JAMA. 2015;313(21):2114. doi:10.1001/jama.2015.5672

Two drugs approved for topical use in humans to treat skin conditions can coax mouse and human oligodendrocyte progenitor cells (OPCs) to mature into oligodendrocytes, which produce the protective myelin sheaths around nerve fibers that are attacked by the immune system in patients with multiple sclerosis (Najm FJ et al. Nature. doi:10.1038/nature14335 [published online April 20, 2015]). Although OPCs are abundant in demyelinated regions of patients with multiple sclerosis, they fail to differentiate.

First Page Preview View Large
First page PDF preview
First page PDF preview
×